Drug
HR17031 injection
HR17031 injection is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
20%
Ph phase_1
2
40%
Ph phase_3
2
40%
Phase Distribution
2
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Other(3)
Detailed Status
unknown3
Completed2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)
Trials by Status
completed240%
unknown360%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
NCT06881264
completedphase_3
A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
NCT06871761
unknownphase_2
A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes
NCT05333835
unknownphase_1
A Trial of HR17031 Injection With Renal Insufficiency
NCT05292495
unknownphase_1
A Trial of HR17031 Injection With Hepatic Insufficiency
NCT05151705
Clinical Trials (5)
Showing 5 of 5 trials
NCT06881264Phase 3
A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
NCT06871761Phase 3
A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
NCT05333835Phase 2
A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes
NCT05292495Phase 1
A Trial of HR17031 Injection With Renal Insufficiency
NCT05151705Phase 1
A Trial of HR17031 Injection With Hepatic Insufficiency
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5